Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Capecitabine × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 37 Stomach Neoplasms 18 Rectal Neoplasms 15 Colorectal Neoplasms 14 Triple Negative Breast Neoplasms 10 Neoplasm Metastasis 10 Esophageal Neoplasms 7 Adenocarcinoma Of Esophagus 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Nasopharyngeal Carcinoma 5 Colonic Neoplasms 5 Adenocarcinoma 5 Recurrence 4 Neoplasms 4 Cholangiocarcinoma 4 Locally Advanced Rectal Cancer 3 Colorectal Cancer Metastatic 3 Brain Neoplasms 3 Biliary Tract Neoplasms 3 Anus Neoplasms 3 Somatostatinoma 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 HER2-positive Gastric Cancer 2 Gallbladder Neoplasms 2 Bile Duct Neoplasms 2 Advanced Solid Tumour 2 Solid Cancer 1 Resectable Colon Cancer 1 Rectal Neoplasms Malignant 1

Interventions

Cyclophosphamide 3 fludarabine 2 Temozolomide 2 Eflornithine 2 ibrutinib 1 gallium Ga 68 dotatate 1 Standard of Care 1 Radiotherapy 1 Etoposide 1 Drug Therapy 1 CLR1404 1 Blood Specimen Collection 1 1-methyltryptophan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡